Market Access Blogs June 28, 2024 States Influence Drug Pricing and Access, Specialty Pharmacies Evolve to Accommodate... 4 Minute Read Read the latest on how states influence drug pricing and access, specialty pharmacies evolution to supoprt cell & gene therapies, and Walgreens entering the CGT arena.
Contracts & Pricing June 12, 2024 The Wild Ride of Medicare Part D Payer Challenges 3 Minute Read Learn about the IRA's changes to Part D benefits have created uncertainty for both manufacturers and payers.
Market Access Blogs May 30, 2024 IRA Part D Redesign, New Gene Therapies Give Hope for Patients,... 5 Minute Read Discover the latest on IRA Part D Redesign Financial Implications, New Gene Therapies Give Newfound Hope for Patients, and Impact of Credit Card Fees in Government Pricing.
Contracts & Pricing April 24, 2024 Changing Pharmacy Reimbursements with CVS, FSS/IFF Reporting Alert & the Latest... 3 Minute Read Discover the latest on the Pharmacy Reimbursements for CVS, FSS/IFF Reporting Alert, and the 340B Drug Discount Program.
Market Access April 18, 2024 10 Market Access Issues & Their Warning Signs 5 Minute Read Navigate market access issues with insights on 10 common warning signs, including outdated legacy mindsets, inadequate data sources, and operational silos.
Contracts & Pricing March 21, 2024 FDA Approves Florida Drug Imports from Canada, GLP-1 Market Dilemma, &... 5 Minute Read Discover the latest on the FDA Approving Florida's Plan to Import Prescription Drugs from Canada, The GLP-1 Market Dilemma, and Illinois Price Gouging Law updates this month.
Gross-to-Net February 20, 2024 Navigating the Complexities of Biopharma/Pharma Net Revenue Forecasting 3 Minute Read The gross-to-net process, essential for understanding net revenue, demands a keen awareness of every piece of data and business drivers upstream. In this blog, we'll explore the critical considerations...
Contracts & Pricing January 31, 2024 The New Medicare Part D Agreement, AMP Removals Impact on WAC... 9 Minute Read Discover the latest on the New Medicare Part D Agreement, 2024 Pharma Industry Shake-Up andth 2023 SPTR Recap updates this month.
Channel January 25, 2024 Transforming Pharmaceutical Trade and Embracing Innovation in Distribution Paradigms 3 Minute Read Learn about this transformative period which poses both challenges and opportunities, urging stakeholders to adapt and innovate.
Gross-to-Net January 11, 2024 3 Tips to Navigating GTN Year-End Audit Prep 6 Minute Read For the majority of life science and biotech companies, January is a time of closing the books, wrapping up year end results, and preparing for the annual audit. This...
